Tredje AP fonden Boosts Stake in Intuitive Surgical, Inc. $ISRG

Tredje AP fonden increased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 120.5% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 171,811 shares of the medical equipment provider’s stock after buying an additional 93,900 shares during the period. Tredje AP fonden’s holdings in Intuitive Surgical were worth $97,307,000 at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. Holos Integrated Wealth LLC purchased a new stake in Intuitive Surgical during the fourth quarter valued at approximately $25,000. Newbridge Financial Services Group Inc. raised its position in Intuitive Surgical by 300.0% during the fourth quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 33 shares during the period. Greykasell Wealth Strategies Inc. purchased a new stake in Intuitive Surgical during the third quarter valued at approximately $27,000. Olistico Wealth LLC purchased a new stake in Intuitive Surgical during the fourth quarter valued at approximately $28,000. Finally, Caitlin John LLC purchased a new stake in Intuitive Surgical during the third quarter valued at approximately $30,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG opened at $439.92 on Tuesday. The business’s 50 day moving average price is $462.50 and its 200-day moving average price is $513.03. Intuitive Surgical, Inc. has a fifty-two week low of $417.74 and a fifty-two week high of $603.88. The company has a market cap of $155.80 billion, a price-to-earnings ratio of 53.32, a PEG ratio of 3.36 and a beta of 1.51.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share for the quarter, topping the consensus estimate of $2.08 by $0.42. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.The firm had revenue of $2.77 billion for the quarter, compared to the consensus estimate of $2.62 billion. During the same period in the prior year, the business posted $1.81 earnings per share. The company’s revenue for the quarter was up 23.0% on a year-over-year basis. Sell-side analysts predict that Intuitive Surgical, Inc. will post 8.57 earnings per share for the current year.

Insider Transactions at Intuitive Surgical

In other news, Director Amy L. Ladd sold 119 shares of the stock in a transaction that occurred on Wednesday, April 29th. The stock was sold at an average price of $463.50, for a total value of $55,156.50. Following the sale, the director directly owned 120 shares in the company, valued at approximately $55,620. This represents a 49.79% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Myriam Curet sold 105 shares of the stock in a transaction that occurred on Tuesday, March 10th. The stock was sold at an average price of $493.95, for a total value of $51,864.75. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 5,647 shares of company stock valued at $2,760,359. Company insiders own 0.60% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on ISRG shares. HSBC decreased their price objective on Intuitive Surgical from $653.00 to $604.00 and set a “buy” rating on the stock in a research report on Wednesday, April 22nd. Barclays set a $651.00 price objective on Intuitive Surgical and gave the company an “overweight” rating in a research report on Thursday, April 23rd. Truist Financial decreased their price objective on Intuitive Surgical from $650.00 to $580.00 and set a “buy” rating on the stock in a research report on Wednesday, April 15th. The Goldman Sachs Group upped their price objective on Intuitive Surgical from $609.00 to $621.00 and gave the company a “buy” rating in a research report on Wednesday, April 22nd. Finally, Raymond James Financial decreased their price objective on Intuitive Surgical from $615.00 to $577.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 22nd. Nineteen investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average target price of $579.33.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.